Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

900 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Sudubrilimab Biosimilar -­ Anti-­CD274 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1717-1MG

ProteoGenix
1 mg Login
Compare
Sugemalimab Biosimilar -­ Anti-­PDL1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1718-100UG

ProteoGenix
100 ug Login
Compare
Sugemalimab Biosimilar -­ Anti-­PDL1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1718-1MG

ProteoGenix
1 mg Login
Compare
Tebotelimab Biosimilar -­ Anti-­PDCD1;LAG3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1722-100UG

ProteoGenix
100 ug Login
Compare
Tebotelimab Biosimilar -­ Anti-­PDCD1;LAG3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1722-1MG

ProteoGenix
1 mg Login
Compare
Telazorlimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1723-100UG

ProteoGenix
100 ug Login
Compare
Telazorlimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1723-1MG

ProteoGenix
1 mg Login
Compare
Tilogotamab Biosimilar -­ Anti-­TNFRSF10B mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1725-100UG

ProteoGenix
100 ug Login
Compare
Tilogotamab Biosimilar -­ Anti-­TNFRSF10B mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1725-1MG

ProteoGenix
1 mg Login
Compare
Vulinacimab Biosimilar -­ Anti-­VEGFR2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1740-100UG

ProteoGenix
100 ug Login
Compare
Vulinacimab Biosimilar -­ Anti-­VEGFR2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1740-1MG

ProteoGenix
1 mg Login
Compare
Zansecimab Biosimilar -­ Anti-­ANGPT2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1741-100UG

ProteoGenix
100 ug Login
Compare
Zansecimab Biosimilar -­ Anti-­ANGPT2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1741-1MG

ProteoGenix
1 mg Login
Compare
Zeluvalimab Biosimilar -­ Anti-­PDCD1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1742-100UG

ProteoGenix
100 ug Login
Compare
Zeluvalimab Biosimilar -­ Anti-­PDCD1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1742-1MG

ProteoGenix
1 mg Login
Compare
Zuberitamab Biosimilar -­ Anti-­MS4A1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1744-100UG

ProteoGenix
100 ug Login
Compare
Zuberitamab Biosimilar -­ Anti-­MS4A1 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1744-1MG

ProteoGenix
1 mg Login
Compare
zimbirelimab Biosimilar -­ Anti-­PD1, PD-­1, CD279 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1745-100UG

ProteoGenix
100 ug Login
Compare
zimbirelimab Biosimilar -­ Anti-­PD1, PD-­1, CD279 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1745-1MG

ProteoGenix
1 mg Login
Compare
Lecanemab Biosimilar -­ Anti-­Amyloid-­beta protofibrils mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1746-100UG

ProteoGenix
100 ug Login
Compare
Lecanemab Biosimilar -­ Anti-­Amyloid-­beta protofibrils mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1746-1MG

ProteoGenix
1 mg Login
Compare
Anti-­MS4A1/­CD20(Homo sapiens) (Ocaratuzumab) Monoclonal Antibody Antibody Primary Other Mammalian cells PX-TA1298-100UG

ProteoGenix
100 ug Login
Compare
Anti-­MS4A1/­CD20(Homo sapiens) (Ocaratuzumab) Monoclonal Antibody Antibody Primary Other Mammalian cells PX-TA1298-1000UG

ProteoGenix
1000 ug Login
Compare
Anti-­TNFSF2/­TNF-­alpha/­TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody Antibody Primary Other Mammalian cells PX-TA1302-100UG

ProteoGenix
100 ug Login
Compare
Anti-­TNFSF2/­TNF-­alpha/­TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody Antibody Primary Other Mammalian cells PX-TA1302-1000UG

ProteoGenix
1000 ug Login
Compare
Name Price
Sudubrilimab Biosimilar -­ Anti-­CD274 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Sugemalimab Biosimilar -­ Anti-­PDL1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Sugemalimab Biosimilar -­ Anti-­PDL1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Tebotelimab Biosimilar -­ Anti-­PDCD1;LAG3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Tebotelimab Biosimilar -­ Anti-­PDCD1;LAG3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Telazorlimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Telazorlimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Tilogotamab Biosimilar -­ Anti-­TNFRSF10B mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Tilogotamab Biosimilar -­ Anti-­TNFRSF10B mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Vulinacimab Biosimilar -­ Anti-­VEGFR2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Vulinacimab Biosimilar -­ Anti-­VEGFR2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Zansecimab Biosimilar -­ Anti-­ANGPT2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Zansecimab Biosimilar -­ Anti-­ANGPT2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Zeluvalimab Biosimilar -­ Anti-­PDCD1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Zeluvalimab Biosimilar -­ Anti-­PDCD1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Zuberitamab Biosimilar -­ Anti-­MS4A1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Zuberitamab Biosimilar -­ Anti-­MS4A1 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
zimbirelimab Biosimilar -­ Anti-­PD1, PD-­1, CD279 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
zimbirelimab Biosimilar -­ Anti-­PD1, PD-­1, CD279 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Lecanemab Biosimilar -­ Anti-­Amyloid-­beta protofibrils mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Lecanemab Biosimilar -­ Anti-­Amyloid-­beta protofibrils mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Anti-­MS4A1/­CD20(Homo sapiens) (Ocaratuzumab) Monoclonal Antibody Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host Mammalian cells
Item no.
Amount 100 ug
Available
Anti-­MS4A1/­CD20(Homo sapiens) (Ocaratuzumab) Monoclonal Antibody Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host Mammalian cells
Item no.
Amount 1000 ug
Available
Anti-­TNFSF2/­TNF-­alpha/­TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host Mammalian cells
Item no.
Amount 100 ug
Available
Anti-­TNFSF2/­TNF-­alpha/­TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host Mammalian cells
Item no.
Amount 1000 ug
Available

900 Item(s)

per page